Teladoc Health appoints Susan Salka, ex-AMN Healthcare CEO, to its board

Teladoc Health, Inc.

Susan Salka appointed to Teladoc board effective March 30, 2026; will serve on audit and compensation committees.
She is former president and CEO of AMN Healthcare, with 33-year tenure; oversaw growth to $5B revenue.
Board expanded to nine members; Salka succeeds retiring directors Eric Evans and Thomas McKinley; Michael Smith previously appointed.
Salka is independent director and qualifies as audit committee financial expert under NYSE/SEC rules.
She currently serves on board of Parexel International and previously served on McKesson, Beckman Coulter, Playtex boards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.